Clinical Trial Update: COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial in metastatic microsatellite-stable colorectal cancer evaluating novel oncology therapies in combination with chemotherapy and bevacizu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: MedImmune LLC | Conditions: Metastatic Microsatellite-stable Colorectal Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-11-15